SPC
Slate Path Capital’s Cyclerion Therapeutics CYCN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-357,880
| Closed | -$927K | – | 54 |
|
|
2024
Q3 | $927K | Hold |
357,880
| – | – | 0.01% | 61 |
|
|
2024
Q2 | $823K | Hold |
357,880
| – | – | 0.02% | 54 |
|
|
2024
Q1 | $1.15M | Hold |
357,880
| – | – | 0.02% | 57 |
|
|
2023
Q4 | $1.2M | Hold |
357,880
| – | – | 0.03% | 54 |
|
|
2023
Q3 | $1.22M | Hold |
357,880
| – | – | 0.03% | 43 |
|
|
2023
Q2 | $1.47M | Sell |
357,880
-6,799,721
| -95% | -$28M | 0.05% | 42 |
|
|
2023
Q1 | $3.11M | Hold |
7,157,601
| – | – | 0.15% | 35 |
|
|
2022
Q4 | $4.7M | Hold |
7,157,601
| – | – | 0.25% | 36 |
|
|
2022
Q3 | $6.16M | Hold |
7,157,601
| – | – | 0.4% | 32 |
|
|
2022
Q2 | $3.93M | Hold |
7,157,601
| – | – | 0.25% | 35 |
|
|
2022
Q1 | $7.95M | Hold |
7,157,601
| – | – | 0.41% | 29 |
|
|
2021
Q4 | $12.3M | Hold |
7,157,601
| – | – | 0.65% | 26 |
|
|
2021
Q3 | $22M | Hold |
7,157,601
| – | – | 1% | 24 |
|
|
2021
Q2 | $27.9M | Buy |
7,157,601
+961,538
| +16% | +$3.75M | 1.56% | 17 |
|
|
2021
Q1 | $17.3M | Hold |
6,196,063
| – | – | 1.12% | 19 |
|
|
2020
Q4 | $19M | Hold |
6,196,063
| – | – | 1.03% | 15 |
|
|
2020
Q3 | $37.7M | Buy |
6,196,063
+5,000,000
| +418% | +$30.4M | 2.14% | 14 |
|
|
2020
Q2 | $7.07M | Hold |
1,196,063
| – | – | 0.42% | 20 |
|
|
2020
Q1 | $3.17M | Buy |
+1,196,063
| New | +$3.17M | 0.24% | 22 |
|
|
2019
Q4 | – | Sell |
-880,000
| Closed | -$10.7M | – | 26 |
|
|
2019
Q3 | $10.7M | Buy |
880,000
+165,982
| +23% | +$2.01M | 0.71% | 14 |
|
|
2019
Q2 | $8.18M | Buy |
+714,018
| New | +$8.18M | 0.37% | 17 |
|